{"ticker": {"uuid": "3b0b41b8-246b-4238-9e82-a53e88ebdba4", "symbol": "I1NC34", "name": "Incyte Corporation", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Incyte Stock: Is INCY Outperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNczFpNHBINTFmRUZRTUx1UlhLcnY2OU9MSk56SDFGYnFMLUFEOW15YkFSS0hnNkVzR0VteDR0ckVpcGlUbWgwUzZLd1Zpa3ZSVktCaUxVWWNkTEVtZF9EWVJSekNaZmx2SjloRUJwUkpWVzlBalhOQlZ6N0RDZ29IcmJzN0lrVTZRcGFCcXFBc2FBM055MXd3THBaeFRSa0I2Rmc?oc=5", "source_name": "Barchart", "published_at": "2026-06-22T09:33:03+00:00", "published_display": "22 Jun 2026 09:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte (INCY) Stock Dips Despite Japan Greenlight for Minjuvi in DLBCL Treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOdnNJbVhSYk16MEVZaXNYdURDYzR0MV82MFUyZ3haNnYwSHVYVWhGaG5MdW9Yb0lYeS10NnE5V2dNUTFac0xpVGkzQi1meDE5TXNjalEwYXBNQ1UzVTVFMjVpQlZfejJxRUJOdmppZzV2SUZjWEtqLWNicHc0eUp4bXhrdXJyTkY4VG9mcEdBdWJnd3MyX3BTcHpqVTljVVlCTFVrMA?oc=5", "source_name": "MoneyCheck", "published_at": "2026-06-19T08:57:15+00:00", "published_display": "19 Jun 2026 08:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte stock drops 6.04% despite new antibody data in myelofibrosis, Incyte reports", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNY240VDdXUnJ2cnFUUGd2Zk1hTnNNNjF2X2JrUExKQ1VNRGR4Z0REVlhNUW9qdktQQzBJUUppcXVDTDFzTnl0YVRoTnRxTmpaOHRBS01zYzVwZkRFR29RUVhOTWVFX2FqaFFveXZydEdmX0VidlJONVBZclhIb3lZVDNGQWdkWmwtZzlpYWJqNkZmc3JIYjU0?oc=5", "source_name": "Traders Union", "published_at": "2026-06-16T05:25:07+00:00", "published_display": "16 Jun 2026 05:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte Corp. stock underperforms Monday when compared to competitors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AJBVV95cUxPb01nbHc3QWNJM1FUclptSEV2U0pSYUtKQU9mQXJUQ05qSzBCRzFuVHRWa0lCWjgyWHZGcDJhNU9pcXdldXB0ZldlUXcxYk01RV96Vnh3M090aHlwX1F5NXdtVzQzcV9HY0x4cWhzQkNkbnk4MXFmcExNZEk2WHVCVG82aWtpcnd3NzNqYWpMaGJSYWk3Y010cC1XekhUdElvaERjVHhnLWkwN2VHQXQ5bFZ4aHU1X2RKTV9lU1Qzb2JqQzZiVFBvZDl6NlEwU0J4a1BvemE4ZmVpUDVUdkF2cFNVS1d4YUZkS0tBanpRcXRHU2tXQVFFU2h2UUpNUi1VNGRoZHV5QnVTZ2RKZXlEdWFlb0dQc2N6Si00RjNpTkVJRDdJTFVTY0lCMnhlT00wZDhMZ09qYXdxNk5COWZnS1dQSzk0UHU2M3ROOFBRb09xQjAz?oc=5", "source_name": "MSN", "published_at": "2026-06-16T00:25:19+00:00", "published_display": "16 Jun 2026 00:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright raises Incyte stock price target to $140 on Vega deal By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNUU04M0xncFgyOUt0VTN2dlB6WC00MWtNR2dMRnJ1WFcycDJNQXp1ZXU1d2p6OVllTmlfMk5CYmFqdklTSlFSS2s0OGk1OHVucWI2WHBHc0ktQW41MmRvMzFaVVJWRl9Zbk1BUlhhemxtN1BoZl9JQUFYTDJRc2Jrd05MYXVvVGxGZzdnaVlIRGxvRDNnejZBTTgtOGdTWG1zdXJLbE9uTmNiZmdQOFdzWkYzTXNxeXhRNlNNdFI5a29LMV9CV2c?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte (INCY) Reports Strong Q1 Earnings with Significant Revenue Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQVhxUjZZNGlmLWZJVE55N3ZNLU5ySjJjaHBMOC10a2YwenhKTkpINlV5VXQ5NmU0cjZOZWcwcWhpb0s1ekMxWUJGbzg0WXhNejUtcWVEcEdtQml0TFVSRTJqT1piekhQb1JBc2Z1MURBdlF5WnRBbDdSWVRDRnBudlBRNHZmbjA1a1lJZ0dMSE40ZDZhRXp1SzFOUHpKc3pxNWE0aFR5eXVRTjdOeDJPV1pSbS1XZlNEZlZ5cEVn?oc=5", "source_name": "GuruFocus", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Incyte Stock Outperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNSmRMbjZJMkVpX09UTkRPWUgyS2pMejRaa2JORkU3ZlA1UlByT0xXOXl5UFRrblI2dU9oVHZhdmFmZ19HVk1vMEt5YW5aZU8tbEQxNzhWNUpHZGl0M1FFQVNkWGdUcURFa2ZxOENicXRXOU82NEdzN2ItOWQtUzNMaWkxT0owSjA?oc=5", "source_name": "Barchart", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte (INCY) Stock Analysis: 6-Month Surge & Financial Health - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQTzdTaUVycVVqbzdnQVd4aENMWks3ZUFaVjZNblRIdkpYX1hiQ3p6bm0tUlRXVFpEZWdiZUdjUjZpMFU4bWNwcm85ZjVFemhTWHhqNkNmblJYS1FqaGpQVHJoR2hPZGFlTVphTGk5RWVXZXFpRDBhT3J1T21TMF9IbGRWSVBHYVNtVk80dWJR?oc=5", "source_name": "IndexBox", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte\u2019s tafasitamab meets primary endpoint in frontMIND trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQRU1CUEJ6VS1hZ0tTU1YzdUhDYm5lY09mU3lYbWtOaWFYTTN4MWhSZjJUWU9QVlZYdV9jQk4tYnFVWUFxUlJFODY5NW5pYkR1WkdLU1VrdFhzVG1zQmdsS25tcWtjOWhEajVVem1tTVVsbGdldWtYYmdGNk1jenpaY3RrMEZJSEp3TzhKZmdtR29aS0ZBVXZneWJyZmQ1YVFyUUY3M0ctU19NRFZwTUNOak9WcGRBSlA2eHc?oc=5", "source_name": "Investing.com", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte and Winnie Harlow Join Forces to Share Her Personal Vitil", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTnd5aWFvMXA4dnFmUkgyXzN6S1dJMWY1Wk45LWxVVXZucFdVRGRWQTJuUThPSXp0YVpNNUhoeExYM0NSZzBSNzFzZmk4YjlYSEZQeHh0Zkl0dHV4QnlhZ2tjZkRMNE1TLW1sWFMtMFA3RzNyemdhdkVyUDdLc19ES09rMnV1SUNES2dSMUlwQWl3em5mWmw3a1dKSVhhTGQwdU9oTGtoU1cyOGtObHZDd2Y3Ql9LYVZ0X096LVdkUHUyVWxTMXVZdGRBYXp0TEk4c2NlVWJFZW1WZktkNVVLVE9iNGFWUHN5?oc=5", "source_name": "GuruFocus", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte stock hit by 11% despite paediatric dermatology trials hitting target", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQODBfRXNMRG9JMk5tTjNvX2hGbjhqYW5RRDJlNnY2X2MxYVIxWEtpVlgxRE9RV0ZGbjd4cHl3T0hMUkJfNnEtTUVEZlN1Y2tMZ1VIZGtKTkgyTUhVWkM0R1FkdVhVQnJKMjRRNzFhNWdMUlJYQjVCeTd0MFAzcExVOURWME5pLWx6Unlib2dGZWpMb3FtVHNDcXJIV2NwZ18tNTl1U3FMUDZpS3NnanhvQzF4MHU?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2025-03-17T07:00:00+00:00", "published_display": "17 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte Stock Price Forecast. Should You Buy INCY?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE1OZHUydFhQVXBVeGlhM3hHQnUtVnNIVUM3UzZWRWRNSzBNajF2V2JzQkhOOFBTMTBLTnhuLThJQ2h1SXhzZF9sUA?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-01T17:57:15+00:00", "published_display": "01 Dec 2020 17:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte Corp (INCY) DCF Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE1jbmExUlg4V2VZbWQ5QXJzdXBFbnU1T0dTNWo1RWlTemJkdnlPX294VE5UakpxU1JzNHg0ejZoZEVyQVFndWtkOTdYMGVLVWJPemc?oc=5", "source_name": "GuruFocus", "published_at": "2019-04-26T05:07:20+00:00", "published_display": "26 Apr 2019 05:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Merck, Incyte IDO inhibitor fails late-stage trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPNkFRbENRQUxoZWFhTEJXWDc4VF8xTUlVekNLRDV2c0dxajg0SDVvOXdhRm0tVEtNSjBwUVlpUlJud3VLRzNwTXdoa19DZzlQd1gzUW0tWlhYTlV1TTB0M0FtNS1tQTZ3VE85YWh5SUoyOWF6dm5QTHYwaV9JYXczdEhIOFFLT3h1aFF1TWxLYU0?oc=5", "source_name": "C&EN", "published_at": "2018-04-13T07:00:00+00:00", "published_display": "13 Apr 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Incyte Stock: Is INCY Outperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNczFpNHBINTFmRUZRTUx1UlhLcnY2OU9MSk56SDFGYnFMLUFEOW15YkFSS0hnNkVzR0VteDR0ckVpcGlUbWgwUzZLd1Zpa3ZSVktCaUxVWWNkTEVtZF9EWVJSekNaZmx2SjloRUJwUkpWVzlBalhOQlZ6N0RDZ29IcmJzN0lrVTZRcGFCcXFBc2FBM055MXd3THBaeFRSa0I2Rmc?oc=5", "source_name": "Barchart", "published_at": "2026-06-22T09:33:03+00:00", "published_display": "22 Jun 2026 09:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte (INCY) Stock Dips Despite Japan Greenlight for Minjuvi in DLBCL Treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOdnNJbVhSYk16MEVZaXNYdURDYzR0MV82MFUyZ3haNnYwSHVYVWhGaG5MdW9Yb0lYeS10NnE5V2dNUTFac0xpVGkzQi1meDE5TXNjalEwYXBNQ1UzVTVFMjVpQlZfejJxRUJOdmppZzV2SUZjWEtqLWNicHc0eUp4bXhrdXJyTkY4VG9mcEdBdWJnd3MyX3BTcHpqVTljVVlCTFVrMA?oc=5", "source_name": "MoneyCheck", "published_at": "2026-06-19T08:57:15+00:00", "published_display": "19 Jun 2026 08:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte stock drops 6.04% despite new antibody data in myelofibrosis, Incyte reports", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNY240VDdXUnJ2cnFUUGd2Zk1hTnNNNjF2X2JrUExKQ1VNRGR4Z0REVlhNUW9qdktQQzBJUUppcXVDTDFzTnl0YVRoTnRxTmpaOHRBS01zYzVwZkRFR29RUVhOTWVFX2FqaFFveXZydEdmX0VidlJONVBZclhIb3lZVDNGQWdkWmwtZzlpYWJqNkZmc3JIYjU0?oc=5", "source_name": "Traders Union", "published_at": "2026-06-16T05:25:07+00:00", "published_display": "16 Jun 2026 05:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte Corp. stock underperforms Monday when compared to competitors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AJBVV95cUxPb01nbHc3QWNJM1FUclptSEV2U0pSYUtKQU9mQXJUQ05qSzBCRzFuVHRWa0lCWjgyWHZGcDJhNU9pcXdldXB0ZldlUXcxYk01RV96Vnh3M090aHlwX1F5NXdtVzQzcV9HY0x4cWhzQkNkbnk4MXFmcExNZEk2WHVCVG82aWtpcnd3NzNqYWpMaGJSYWk3Y010cC1XekhUdElvaERjVHhnLWkwN2VHQXQ5bFZ4aHU1X2RKTV9lU1Qzb2JqQzZiVFBvZDl6NlEwU0J4a1BvemE4ZmVpUDVUdkF2cFNVS1d4YUZkS0tBanpRcXRHU2tXQVFFU2h2UUpNUi1VNGRoZHV5QnVTZ2RKZXlEdWFlb0dQc2N6Si00RjNpTkVJRDdJTFVTY0lCMnhlT00wZDhMZ09qYXdxNk5COWZnS1dQSzk0UHU2M3ROOFBRb09xQjAz?oc=5", "source_name": "MSN", "published_at": "2026-06-16T00:25:19+00:00", "published_display": "16 Jun 2026 00:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright raises Incyte stock price target to $140 on Vega deal By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNUU04M0xncFgyOUt0VTN2dlB6WC00MWtNR2dMRnJ1WFcycDJNQXp1ZXU1d2p6OVllTmlfMk5CYmFqdklTSlFSS2s0OGk1OHVucWI2WHBHc0ktQW41MmRvMzFaVVJWRl9Zbk1BUlhhemxtN1BoZl9JQUFYTDJRc2Jrd05MYXVvVGxGZzdnaVlIRGxvRDNnejZBTTgtOGdTWG1zdXJLbE9uTmNiZmdQOFdzWkYzTXNxeXhRNlNNdFI5a29LMV9CV2c?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte (INCY) Reports Strong Q1 Earnings with Significant Revenue Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQVhxUjZZNGlmLWZJVE55N3ZNLU5ySjJjaHBMOC10a2YwenhKTkpINlV5VXQ5NmU0cjZOZWcwcWhpb0s1ekMxWUJGbzg0WXhNejUtcWVEcEdtQml0TFVSRTJqT1piekhQb1JBc2Z1MURBdlF5WnRBbDdSWVRDRnBudlBRNHZmbjA1a1lJZ0dMSE40ZDZhRXp1SzFOUHpKc3pxNWE0aFR5eXVRTjdOeDJPV1pSbS1XZlNEZlZ5cEVn?oc=5", "source_name": "GuruFocus", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Incyte Stock Outperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNSmRMbjZJMkVpX09UTkRPWUgyS2pMejRaa2JORkU3ZlA1UlByT0xXOXl5UFRrblI2dU9oVHZhdmFmZ19HVk1vMEt5YW5aZU8tbEQxNzhWNUpHZGl0M1FFQVNkWGdUcURFa2ZxOENicXRXOU82NEdzN2ItOWQtUzNMaWkxT0owSjA?oc=5", "source_name": "Barchart", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte (INCY) Stock Analysis: 6-Month Surge & Financial Health - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQTzdTaUVycVVqbzdnQVd4aENMWks3ZUFaVjZNblRIdkpYX1hiQ3p6bm0tUlRXVFpEZWdiZUdjUjZpMFU4bWNwcm85ZjVFemhTWHhqNkNmblJYS1FqaGpQVHJoR2hPZGFlTVphTGk5RWVXZXFpRDBhT3J1T21TMF9IbGRWSVBHYVNtVk80dWJR?oc=5", "source_name": "IndexBox", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte\u2019s tafasitamab meets primary endpoint in frontMIND trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQRU1CUEJ6VS1hZ0tTU1YzdUhDYm5lY09mU3lYbWtOaWFYTTN4MWhSZjJUWU9QVlZYdV9jQk4tYnFVWUFxUlJFODY5NW5pYkR1WkdLU1VrdFhzVG1zQmdsS25tcWtjOWhEajVVem1tTVVsbGdldWtYYmdGNk1jenpaY3RrMEZJSEp3TzhKZmdtR29aS0ZBVXZneWJyZmQ1YVFyUUY3M0ctU19NRFZwTUNOak9WcGRBSlA2eHc?oc=5", "source_name": "Investing.com", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte and Winnie Harlow Join Forces to Share Her Personal Vitil", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTnd5aWFvMXA4dnFmUkgyXzN6S1dJMWY1Wk45LWxVVXZucFdVRGRWQTJuUThPSXp0YVpNNUhoeExYM0NSZzBSNzFzZmk4YjlYSEZQeHh0Zkl0dHV4QnlhZ2tjZkRMNE1TLW1sWFMtMFA3RzNyemdhdkVyUDdLc19ES09rMnV1SUNES2dSMUlwQWl3em5mWmw3a1dKSVhhTGQwdU9oTGtoU1cyOGtObHZDd2Y3Ql9LYVZ0X096LVdkUHUyVWxTMXVZdGRBYXp0TEk4c2NlVWJFZW1WZktkNVVLVE9iNGFWUHN5?oc=5", "source_name": "GuruFocus", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte stock hit by 11% despite paediatric dermatology trials hitting target", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQODBfRXNMRG9JMk5tTjNvX2hGbjhqYW5RRDJlNnY2X2MxYVIxWEtpVlgxRE9RV0ZGbjd4cHl3T0hMUkJfNnEtTUVEZlN1Y2tMZ1VIZGtKTkgyTUhVWkM0R1FkdVhVQnJKMjRRNzFhNWdMUlJYQjVCeTd0MFAzcExVOURWME5pLWx6Unlib2dGZWpMb3FtVHNDcXJIV2NwZ18tNTl1U3FMUDZpS3NnanhvQzF4MHU?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2025-03-17T07:00:00+00:00", "published_display": "17 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte Stock Price Forecast. Should You Buy INCY?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE1OZHUydFhQVXBVeGlhM3hHQnUtVnNIVUM3UzZWRWRNSzBNajF2V2JzQkhOOFBTMTBLTnhuLThJQ2h1SXhzZF9sUA?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-01T17:57:15+00:00", "published_display": "01 Dec 2020 17:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incyte Corp (INCY) DCF Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE1jbmExUlg4V2VZbWQ5QXJzdXBFbnU1T0dTNWo1RWlTemJkdnlPX294VE5UakpxU1JzNHg0ejZoZEVyQVFndWtkOTdYMGVLVWJPemc?oc=5", "source_name": "GuruFocus", "published_at": "2019-04-26T05:07:20+00:00", "published_display": "26 Apr 2019 05:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Merck, Incyte IDO inhibitor fails late-stage trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPNkFRbENRQUxoZWFhTEJXWDc4VF8xTUlVekNLRDV2c0dxajg0SDVvOXdhRm0tVEtNSjBwUVlpUlJud3VLRzNwTXdoa19DZzlQd1gzUW0tWlhYTlV1TTB0M0FtNS1tQTZ3VE85YWh5SUoyOWF6dm5QTHYwaV9JYXczdEhIOFFLT3h1aFF1TWxLYU0?oc=5", "source_name": "C&EN", "published_at": "2018-04-13T07:00:00+00:00", "published_display": "13 Apr 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 66, "total_relevant": 15, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 11, "score": 54, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 5.5, "count": 10}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 253.5, "latest_week": "2026-06-19", "one_week_move": -7.0, "four_week_move": 5.3, "twelve_week_move": 6.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.208699, "market_dynamics_buy_signal": false, "relative_strength": -0.930182, "fair_value_gap": 27.5, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 21.8317, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.0% over one week, +5.3% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "GuruFocus", "count": 3}, {"label": "Barchart", "count": 2}, {"label": "MoneyCheck", "count": 1}, {"label": "Traders Union", "count": 1}, {"label": "MSN", "count": 1}, {"label": "Investing.com South Africa", "count": 1}, {"label": "Market source", "count": 1}, {"label": "IndexBox", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 10}, {"label": "Analyst action", "count": 2}, {"label": "Earnings", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-7.0% over one week, +5.3% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Incyte Stock: Is INCY Outperforming the Healthcare Sector?"}], "updated_at": "2026-06-22T21:15:01.392314+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}